A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (COVID-19)

We review here the origin, outbreak characteristics and main epidemiological features of the novel Coronavirus (2019nCoV) responsible of a new coronavirus disease (COVID-19). Rapid global health authorities’ responses are now in course and international scientific collaboration is urgently need. Previous outbreaks experiences with similar viral agents have increased the capacity to containment and control of these recurrent health menaces.

[1]  A. Rodríguez-Morales,et al.  Going global – Travel and the 2019 novel coronavirus , 2020, Travel Medicine and Infectious Disease.

[2]  A. Rodríguez-Morales,et al.  SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? – A bibliometric analysis , 2020, Travel Medicine and Infectious Disease.

[3]  S. Lindstrom,et al.  First Case of 2019 Novel Coronavirus in the United States , 2020, The New England journal of medicine.

[4]  H. Hashimoto,et al.  Comparison of the Amino Acid Sequence and Phylogenetic Analysis of the Peplomer, Integral Membrane and Nucleocapsid Proteins of Feline, Canine and Porcine Coronaviruses , 1996, Microbiology and immunology.

[5]  M. Friedrich.  WHO's Blueprint List of Priority Diseases. , 2018, JAMA.

[6]  G. Gartlehner,et al.  [Communicating Risk in Public Health Emergencies: A WHO Guideline for Emergency Risk Communication (Erc) Policy and Practice]. , 2019, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[7]  Zhènglì Shí,et al.  Origin and evolution of pathogenic coronaviruses , 2018, Nature Reviews Microbiology.

[8]  A. Rodríguez-Morales,et al.  History is repeating itself, a probable zoonotic spillover as a cause of an epidemic: the case of 2019 novel Coronavirus. , 2020, Le infezioni in medicina.

[9]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[10]  F. Ostanello,et al.  Quasispecies composition and phylogenetic analysis of feline coronaviruses (FCoVs) in naturally infected cats , 2003, FEMS Immunology and Medical Microbiology.

[11]  N. Lurie,et al.  Finding equipoise: CEPI revises its equitable access policy , 2020, Vaccine.

[12]  Alimuddin Zumla,et al.  Travel implications of emerging coronaviruses: SARS and MERS-CoV , 2014, Travel Medicine and Infectious Disease.

[13]  G. Gao,et al.  T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV , 2016, Antiviral Research.

[14]  Gavin J. D. Smith,et al.  Detection and Phylogenetic Analysis of Group 1 Coronaviruses in South American Bats , 2008, Emerging infectious diseases.

[15]  J. Castellanos,et al.  Human Metapneumovirus: Laboratory Methods for Isolation, Propagation, and Plaque Titration , 2019, Intervirology.

[16]  T. Lam,et al.  Phylogenetic perspectives on the epidemiology and origins of SARS and SARS-like coronaviruses , 2009, Infection, Genetics and Evolution.

[17]  Wu Zhong,et al.  Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro , 2020, Cell Research.

[18]  A. RodrÍguez-Morales,et al.  La comunicación científica y el acceso abierto en la contención de enfermedades: El caso del Coronavirus novel 2019 (2019-nCoV) , 2020 .

[19]  B. Scarpellini,et al.  Systematic review on respiratory syncytial virus epidemiology in adults and the elderly in Latin America , 2019, International Journal of Infectious Diseases.

[20]  Alfonso J. Rodriguez-Morales,et al.  Coronavirus infections reported by ProMED, February 2000–January 2020 , 2020, Travel Medicine and Infectious Disease.

[21]  R. Charrel,et al.  Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[22]  Gerald Gartlehner,et al.  [Communicating Risk in Public Health Emergencies: A WHO Guideline for Emergency Risk Communication (Erc) Policy and Practice]. , 2019, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[23]  K. Yuen,et al.  Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou , 2018, PloS one.

[24]  R. Wunderink,et al.  MERS, SARS and other coronaviruses as causes of pneumonia , 2017, Respirology.

[25]  Q. Pham,et al.  Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam , 2020, The New England journal of medicine.

[26]  J. A. Comer,et al.  A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[27]  M. David,et al.  Prevalence, clinical outcomes and rainfall association of acute respiratory infection by human metapneumovirus in children in Bogotá, Colombia , 2019, BMC Pediatrics.

[28]  Xuming Zhang,et al.  The hemagglutinin/esterase gene of human coronavirus strain OC43: Phylogenetic relationships to bovine and murine coronaviruses and influenza C virus☆ , 1992, Virology.

[29]  Qiyong Liu,et al.  The Epidemic Dynamics of 2019 Novel Coronavirus (2019-nCoV) Infections in China by 28 January , 2020 .

[30]  J. Al-Tawfiq,et al.  Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Extent and implications for infection control: A systematic review , 2018, Travel Medicine and Infectious Disease.

[31]  G. Gao,et al.  Origin and Possible Genetic Recombination of the Middle East Respiratory Syndrome Coronavirus from the First Imported Case in China: Phylogenetics and Coalescence Analysis , 2015, mBio.

[32]  Shengwang Liu,et al.  Phylogenetic analysis of infectious bronchitis coronaviruses newly isolated in China, and pathogenicity and evaluation of protection induced by Massachusetts serotype H120 vaccine against QX-like strains , 2011, Avian pathology : journal of the W.V.P.A.

[33]  I. Uchida,et al.  Phylogenetic studies of bovine coronaviruses isolated in Japan. , 2009, The Journal of veterinary medical science.

[34]  M. Sircar,et al.  Pneumonia of unknown cause. , 1990, The European respiratory journal.

[35]  Yanjie Zhao,et al.  A47 Origin and possible genetic recombination of the middle east respiratory syndrome coronavirus from the first imported case in china: phylogenetics and coalescence analysis , 2017, Virus evolution.

[36]  A. Rodríguez-Morales,et al.  The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? – Interim recommendations January 2020, from the Latin-American society for Travel Medicine (SLAMVI) , 2020, Travel Medicine and Infectious Disease.

[37]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[38]  C. Stephensen,et al.  Phylogenetic analysis of a highly conserved region of the polymerase gene from 11 coronaviruses and development of a consensus polymerase chain reaction assay , 1999, Virus Research.